Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Insurance Press Releases.
Press releases published on June 30, 2025
IMUNON Submits Plan in Consultation with the Exchange to Ensure Compliance with Nasdaq’s Listing Requirement, Anticipates Additional Compliance Period
GlobeNewswire
·
June 30, 2025
LAWRENCEVILLE, N.J., June 30, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that, in consultation with The Nasdaq Stock Market LLC (Nasdaq), it has …
Freshworks Launches Freshservice Journeys to Make Work Life Easier by Removing Frustration from Employee Experiences
GlobeNewswire
·
June 30, 2025
SAN MATEO, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Freshworks (NASDAQ: FRSH), today announced the general availability of Freshservice Journeys, a new AI-assisted capability within its IT and employee service management offering, designed to streamline …
HealthLynked Appoints Andrew Mavliev as Chief Technology and Product Officer to Accelerate Direct-to-Consumer Healthcare Innovation
GlobeNewswire
·
June 30, 2025
NAPLES, Fla., June 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a leader in connected healthcare technology, is pleased to announce the appointment of Andrew Mavliev as its new Chief Technology and Product Officer. With over 15 …
Tectonic Therapeutic Joins Russell 3000® Index
GlobeNewswire
·
June 30, 2025
WATERTOWN, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of …
Revolution Medicines and Summit Therapeutics Enter into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors with Ivonescimab in RAS Mutant Tumors
GlobeNewswire
·
June 30, 2025
REDWOOD CITY, Calif. and MIAMI, June 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers and Summit Therapeutics, Inc. (Nasdaq: …
Spectral AI Announces Submission to FDA of its DeepView® System
GlobeNewswire
·
June 30, 2025
DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 …
Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
GlobeNewswire
·
June 30, 2025
SAN DIEGO, June 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its addition to the Russell 2000® …
Protara Therapeutics Announces Addition to the Russell 3000® Index
GlobeNewswire
·
June 30, 2025
NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that the Company has been added as a member …
Chemomab Announces Oral Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis at BSG Live’25
GlobeNewswire
·
June 30, 2025
SPRING Trial Data Presented at BSG Live’25 Confirms the Clinical Potential of Nebokitug as a First-in-Class Novel Treatment for PSC and Supports Advancement to Phase 3 Treatment with Nebokitug Is Well-Tolerated and Associated with Substantial Improvements …
Transom-Backed Secur-Serv Completes Fifth Add-On Acquisition, Delivers M&A Growth Story
GlobeNewswire
·
June 30, 2025
LOS ANGELES, June 30, 2025 (GLOBE NEWSWIRE) -- Secur-Serv (www.secur-serv.com), a market-leading managed services provider backed by Transom Capital Group (“Transom”), announced it has completed the acquisition of Arrowhead Technologies, a Fort Worth, …
Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China
GlobeNewswire
·
June 30, 2025
Builds on clearances already received by FDA and EMA China has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage …
Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings
GlobeNewswire
·
June 30, 2025
FDA provides supportive feedback on proposed statistical analysis plan for neurofilament biomarker analysis of Clene’s NIH-sponsored Expanded Access Program NfL EAP biomarker analyses to be conducted early in the 4th Quarter of 2025 Clene confirms two …
Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
GlobeNewswire
·
June 30, 2025
No treatment-related neuropsychiatric events seen to date in SAD portion of Phase 1 MAD study on track for completion in Q3 2025 NORWOOD, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company …
Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement
GlobeNewswire
·
June 30, 2025
LAGUNA HILLS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), a pioneer in ophthalmic technologies and the first publicly-listed U.S. company to build a strategic treasury of HYPE, the native token of …
Apollo Announces Olympus Housing Capital
GlobeNewswire
·
June 30, 2025
NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced the launch of Olympus Housing Capital (“Olympus” or the “Company”), a new homebuilder finance strategy. Olympus is an affiliate of Apollo and focuses on providing capital …
Kratos Defense & Security Solutions, Inc. Announces Completion of Public Offering of $575 Million of Common Stock at $38.50 Per Share
GlobeNewswire
·
June 30, 2025
SAN DIEGO, June 30, 2025 (GLOBE NEWSWIRE) -- Kratos Defense …
Aimfinity Investment Corp. I Announces New Monthly Extension for Business Combination
GlobeNewswire
·
June 30, 2025
Wilmington, DE, June 30, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the “AIMA”) (Nasdaq: AIMTF), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which …
Uni-Fuels Strengthens Asian Market Presence with A New Office in Shanghai
GlobeNewswire
·
June 30, 2025
SINGAPORE, June 30, 2025 (GLOBE NEWSWIRE) -- Uni-Fuels Holdings Limited (NASDAQ: UFG), (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions headquartered in Singapore, today announced the opening of a new office in Shanghai. As part …
Garrett Motion added to Russell 2000® Index
GlobeNewswire
·
June 30, 2025
PLYMOUTH, Mich. and ROLLE, Switzerland, June 30, 2025 (GLOBE NEWSWIRE) -- Garrett Motion Inc. (Nasdaq: GTX) (“Garrett” or the “Company”), a leading differentiated automotive technology provider, today announced that the Company joined the Russell 2000® …
Ferroglobe PLC Joins the Russell 2000® and Russell 3000® Indexes
GlobeNewswire
·
June 30, 2025
LONDON, June 30, 2025 (GLOBE NEWSWIRE) -- Ferroglobe PLC (NASDAQ: GSM), a leading global producer of silicon metal, silicon-based and manganese-based specialty alloys, announces its inclusion in the Russell 2000® and Russell 3000® Indexes effective today. …